Leveraging radiotherapy to improve immunotherapy outcomes: rationale, progress and research priorities
Abstract The most successful immunotherapies for solid malignancies to date, immune checkpoint inhibitors, target the essential role of T cells in antitumor immunity. However, T‐cell dysfunction presents a major hindrance to treatment efficacy, warranting research into combined treatment strategies...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2025-01-01
|
| Schriftenreihe: | Clinical & Translational Immunology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/cti2.70030 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|